Huntsman Cancer Institute (HCI) is part of University of Utah Health Care. Every year, HCI serves thousands of cancer patients from Utah and the surrounding states. HCI also teaches and trains future doctors, nurses, and scientists. HCI is the only National Cancer Institute-Designated Cancer Center in the Intermountain West. This means it meets the highest national standards for cancer care and research and receives support for its scientific endeavors. HCI is also a member of the National Comprehensive Cancer Network (NCCN), a not-for-profit alliance of the world’s leading cancer centers. NCCN is dedicated to improving the quality and effectiveness of care provided to patients with cancer.

Thank You for Choosing HCI

We work hard to make sure you have an exceptional experience with the best possible results. We listen and respond to what you and other patients tell us. It is our mission to understand cancer from its beginnings, to use that knowledge in the creation and improvement of cancer treatments, to relieve the suffering of cancer patients, and to provide education about cancer risk, prevention, and care.

Recent News

News, In The Media

Actors Jeremy Renner and Elizabeth Olsen Visit Huntsman Cancer Institute Patients and Staff

Actors Jeremy Renner and Elizabeth Olsen spent two hours visiting patients at Huntsman Cancer Institute on Sunday, January 22. The “Avengers: Age of Ultron” and “Captain America: Civil War” co-stars were in town promoting their Sundance film “Wind River.” Before flying back to Los Angeles, they took time to stop by the hospital and talk with cancer patients and staff.

Read More

Press Releases, In The Media

Huntsman Cancer Institute Scientists Identify Bone Degradation Process Within Metastatic Breast Cancer

Once breast cancer spreads through the body, it can degrade a patient’s healthy bones, causing numerous problems. Scientists at Huntsman Cancer Institute (HCI) at the University of Utah have identified a new way that bones get destroyed through cancer. And they’ve also learned how to block that destruction with a new drug. Initial tests with patients show promising results.

Read More